Bromfenac: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Nonsteroidal anti-inflammatory drug}} | |||
[[File:Bromfenac.svg|thumb|right|Bromfenac chemical structure]] | |||
Bromfenac | |||
'''Bromfenac''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID) used primarily in the treatment of [[ocular inflammation]] and pain following [[cataract surgery]]. It is available in the form of an [[ophthalmic solution]] and is known for its ability to inhibit the [[cyclooxygenase]] (COX) enzymes, which play a key role in the inflammatory process. | |||
== | ==Pharmacology== | ||
Bromfenac | Bromfenac works by inhibiting the [[cyclooxygenase]] enzymes, specifically COX-1 and COX-2, which are involved in the conversion of [[arachidonic acid]] to [[prostaglandins]]. Prostaglandins are mediators of inflammation, and their inhibition leads to reduced inflammation and pain. Bromfenac is particularly effective in reducing ocular inflammation due to its ability to penetrate ocular tissues efficiently. | ||
== | ==Medical uses== | ||
Bromfenac is primarily used in the management of postoperative inflammation and reduction of ocular pain in patients who have undergone [[cataract surgery]]. It is administered as an eye drop, typically once or twice daily, depending on the formulation and the specific needs of the patient. | |||
Serious side effects are rare but | ==Side effects== | ||
Common side effects of bromfenac include mild to moderate [[eye irritation]], [[conjunctival hyperemia]], and [[eye pain]]. Serious side effects are rare but can include [[corneal thinning]], [[corneal erosion]], and [[delayed healing]]. Patients are advised to report any unusual symptoms to their healthcare provider. | |||
==Chemistry== | |||
[[File:Bromfenac_cyclic_amide.svg|thumb|left|Bromfenac cyclic amide structure]] | |||
Bromfenac is chemically known as 2-amino-3-(4-bromobenzoyl)phenylacetic acid. It is a derivative of [[amfenac]], with a bromine atom added to enhance its anti-inflammatory properties. The presence of the bromine atom increases the lipophilicity of the molecule, allowing for better penetration into ocular tissues. | |||
== | ==Comparison with Amfenac== | ||
Bromfenac is | [[File:Brom_vs_Amf.jpg|thumb|right|Comparison of Bromfenac and Amfenac]] | ||
Bromfenac is closely related to [[amfenac]], another NSAID used in ophthalmology. The primary difference between the two is the presence of a bromine atom in bromfenac, which enhances its potency and duration of action compared to amfenac. This modification allows bromfenac to be used at lower concentrations while maintaining efficacy. | |||
== | ==Related pages== | ||
* [[Nonsteroidal anti-inflammatory drug]] | |||
* [[Cyclooxygenase]] | |||
* [[Cataract surgery]] | |||
* [[Ophthalmic solution]] | |||
[[Category:Nonsteroidal anti-inflammatory drugs]] | [[Category:Nonsteroidal anti-inflammatory drugs]] | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category: | [[Category:Acetic acids]] | ||
Latest revision as of 11:02, 23 March 2025
Nonsteroidal anti-inflammatory drug
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) used primarily in the treatment of ocular inflammation and pain following cataract surgery. It is available in the form of an ophthalmic solution and is known for its ability to inhibit the cyclooxygenase (COX) enzymes, which play a key role in the inflammatory process.
Pharmacology[edit]
Bromfenac works by inhibiting the cyclooxygenase enzymes, specifically COX-1 and COX-2, which are involved in the conversion of arachidonic acid to prostaglandins. Prostaglandins are mediators of inflammation, and their inhibition leads to reduced inflammation and pain. Bromfenac is particularly effective in reducing ocular inflammation due to its ability to penetrate ocular tissues efficiently.
Medical uses[edit]
Bromfenac is primarily used in the management of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. It is administered as an eye drop, typically once or twice daily, depending on the formulation and the specific needs of the patient.
Side effects[edit]
Common side effects of bromfenac include mild to moderate eye irritation, conjunctival hyperemia, and eye pain. Serious side effects are rare but can include corneal thinning, corneal erosion, and delayed healing. Patients are advised to report any unusual symptoms to their healthcare provider.
Chemistry[edit]
Bromfenac is chemically known as 2-amino-3-(4-bromobenzoyl)phenylacetic acid. It is a derivative of amfenac, with a bromine atom added to enhance its anti-inflammatory properties. The presence of the bromine atom increases the lipophilicity of the molecule, allowing for better penetration into ocular tissues.
Comparison with Amfenac[edit]
Bromfenac is closely related to amfenac, another NSAID used in ophthalmology. The primary difference between the two is the presence of a bromine atom in bromfenac, which enhances its potency and duration of action compared to amfenac. This modification allows bromfenac to be used at lower concentrations while maintaining efficacy.
